New BioArbitrage LLC Fund IV Launches with Orphan Drug Investment Focus NEW YORK, N.Y., March 3, 2015 (GLOBE NEWSWIRE) -- via PRWEB - The BioArbitrage family of funds has announced the formation of BioArbitrage IV which will focus on rare diseases through the investment...